314140 — RP Bio lnc Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for RP Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Interim Report	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	—	4,616	3,813	4,316	5,437
Depreciation
Amortisation
Non-Cash Items	—	1,903	4,464	8,033	4,336
Unusual Items
Other Non-Cash Items
Changes in Working Capital	6,682	-4,478	-4,021	-16,596	-5,241
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,682	6,455	9,459	1,155	10,580
Capital Expenditures	-36,531	-11,704	-7,271	-5,279	-11,164
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,856	7,100	105	-660	-7,100
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-31,675	-4,603	-7,166	-5,939	-18,264
Financing Cash Flow Items	—	—	—	-502	-3.79
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	20,060	4,160	-3,392	15,332	-5,924
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4,932	6,011	-1,099	10,547	-13,608